RE:RE:RE:RE:RE:RE:If I could run 5X faster than the competition...lscfa wrote: Vote no to the merger. If it goes ahead, vote Gagnon off the board next AGM.
How much money will CZO have left if this merger fails by the end of the first quarter 2024? Gilles said CZO had $10 million cash in the October presentation. Q4 looks like a significant loss with the ramp-up of the avenanthramide clinical trial, simultaneous PGX scale-up of the 5X and 10X plants, and the costs incurred for this merger. There could be a $500,000 breakup fee for the merger. There was no indication CZO's major client had ordered for Q1 2024 suggesting another significant loss; especially with the avenanthramide trial and simultaneous work on the 5X and 10X scale-up. How much money left after Q1 2024.